Study Confirms Link Between Analgesic Use, Ovarian Cancer

Case-control study shows any analgesic, aspirin use may reduce risk of ovarian cancer

THURSDAY, Oct. 11 (HealthDay News) -- Use of any analgesic or aspirin correlates with a reduced risk of ovarian cancer, with the reduction significant only for use of any analgesic and serous ovarian cancer, according to a case-control study published in the September issue of ACTA Obstetricia et Gynecologica Scandinavica.

Henriette B. Ammundsen, from the Danish Cancer Society Research Center in Copenhagen, and colleagues examined the correlation between analgesic use and the risk of ovarian cancer, and whether the risk differed according to histological type. The study cohort included 756 women with epithelial ovarian cancer and 1,564 randomly selected control women, aged 35 to 79 years.

The researchers found a reduced risk of ovarian cancer to be associated with regular use of any analgesic or aspirin, but the reduction was not statistically significant. The risk of ovarian cancer was not decreased with regular use of non-aspirin non-steroidal anti-inflammatory drugs, paracetamol, or other analgesics. There was a statistically significant decrease in the risk of serous ovarian cancer, but not mucinous or other ovarian tumors, with use of any analgesic (odds ratio [OR], 0.72; 95 percent confidence interval [CI], 0.53 to 0.98) or aspirin (OR, 0.60; 95 percent CI, 0.36 to 1.00).

"In conclusion, the results of this case-control study indicate a possible protective effect of analgesic use in relation to development of ovarian cancer," the authors write. "Thus our results support findings from most previous studies."

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events